Hiromasa Tanaka MS, PhD

Hiromasa Tanaka was born in Japan in 1976. He received the B.S., M.S., and Ph.D. degrees in physics from the University of Tokyo, Tokyo, Japan, in 1999, 2001, and 2004, respectively. He was with the Yi Lab, University of California, Irvine, working on systems biology that focuses on complex interactions within biological systems, from 2004 to 2010. He studied the yeast mating signaling systems. To study functional genomics which is a field of systems biology that attempts to make use of the vast wealth of data produced by genomic projects, he moved to the Boone and Moffat Lab, University of Toronto, from 2010--2011.

Hiromasa was involved in a big project to identify cancer therapeutic targets by synthetic lethal screens using a lentivirus-based shRNA knock-down library. Then, he came to the Hori Lab, at Nagoya University, to study his current joint project, plasma medicine. He is working on cancer therapy using non-thermal atmospheric pressure plasma. He has found selective killing of glioblastoma brain tumor cells using a plasma-activated medium and proposed intracellular molecular mechanisms.